Ionis Pharmaceuticals is poised to redefine its market position with ambitious peak sales forecasts of $2 billion for its newly…
Read More
Immunai and Boehringer Ingelheim Forge Strategic Alliance to Uncover Novel T-Cell Targets in Oncology and Autoimmune Diseases
Immunai, a leading artificial intelligence (AI) company specializing in immune system analysis, and Boehringer Ingelheim, a global biopharmaceutical giant, have…
Read More
Top pharma companies set sustainability goals, but emissions are still increasing
The global healthcare industry, a cornerstone of human well-being and longevity, is simultaneously a significant contributor to the planet’s environmental…
Read More
US Life Sciences Investment Woes Leave Nation Vulnerable as China Cultivates Future Big Pharma Competitors
San Diego, CA – The landscape of global biopharmaceutical innovation is undergoing a significant shift, with concerns mounting among investors…
Read More
Eli Lilly and Oura Health Forge Strategic Alliance to Pioneer Integrated Obesity Care
The landscape of obesity treatment is undergoing a profound transformation, moving beyond purely pharmaceutical interventions to embrace a holistic ecosystem…
Read More
Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma
Boston, MA – As Peter Gassner, CEO of Veeva Systems, a dominant cloud software provider in the life sciences sector,…
Read More
Novartis and Antares Therapeutics Forge Landmark Oncology Collaboration to Tackle Undruggable Cancer Targets
In a significant move poised to accelerate the development of novel cancer therapies, Novartis has entered into a strategic collaboration…
Read More
The Future of Cell and Gene Therapy Manufacturing is Being Revolutionized by AI and Advanced Data Strategies
San Diego, CA – The complex landscape of cell and gene therapy manufacturing, a field consistently challenged by the transition…
Read More
NVIDIA Unveils BioNeMo Agent Toolkit to Accelerate Life Sciences R&D with AI
San Diego, CA – NVIDIA has officially launched the BioNeMo agent toolkit, a groundbreaking suite of tools specifically engineered to…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
Across the global pharmaceutical landscape, an estimated 5,000 potential treatments for rare diseases are currently languishing on corporate shelves, representing…
Read More
